[EN] TRIAZOLONE COMPOUNDS<br/>[FR] COMPOSÉS DE TRIAZOLONE
申请人:ASTRAZENECA AB
公开号:WO2021191376A1
公开(公告)日:2021-09-30
Described herein are triazolone compounds of Formula (I): and pharmaceutically acceptable salts thereof. Methods of making and using compounds of Formula (I) are also described. Compounds of Formula (I) and pharmaceutically acceptable salts thereof can be useful as adenosine receptor antagonists, for example in the treatment of diseases or conditions mediated by the adenosine receptor, such as cancer, movement disorders, or attention disorders.